hydrochlorothiazide and pf 04971729

hydrochlorothiazide has been researched along with pf 04971729 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amin, NB; Lee, DS; Mitchell, JR; Nucci, G; Rusnak, JM; Wang, X	1

Trials

1 trial(s) available for hydrochlorothiazide and pf 04971729

Article	Year
Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension. Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:8 Topics: Aldosterone; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Female; Glycosuria; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Male; Renin	2015

Article

Year

Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension.

Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:8

Topics: Aldosterone; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Female; Glycosuria; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Male; Renin

2015